ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Birmingham, AL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Stomach Cancer
Cancer
Ovarian Cancer
Neoplasm Metastasis
Breast Cancer

Pancreatic Cancer trials near Birmingham, AL, USA:

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach (ARTIA-Pancreas)

of borderline-resectable, locally-advanced , or medically inoperable pancreatic adenocarcinoma will translate into a decreased toxicity. The...

Enrolling
Pancreatic Cancer
Radiation: Daily Adaptive External Beam Radiation Therapy
Varian

Birmingham, Alabama, United States and 3 other locations

This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread...

Enrolling
Metastatic Pancreatic Carcinoma
Stage IV Pancreatic Cancer AJCC v8
Drug: Pemigatinib
Procedure: Bone Scan

Phase 2

Sameek Roychowdhury

Birmingham, Alabama, United States and 108 other locations

This study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, ...

Enrolling
Pancreatic Adenocarcinoma
Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
Drug: ASP546C

Phase 1, Phase 2

Astellas
Astellas

Birmingham, Alabama, United States and 21 other locations

in patients aged ≥ 18 years with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC), non-small cell lung cancer...

Enrolling
HR+/HER2- Ductal and Lobular Breast Cancer
Non-small Cell Lung Cancer
Drug: [68Ga]Ga-NNS309
Drug: [177Lu]Lu-NNS309

Phase 1

Novartis
Novartis

Birmingham, Alabama, United States and 28 other locations

with gemcitabine, nab-paclitaxel (G-nP) or gemcitabine, nab-paclitaxel (G-nP) and atezolizumab in previously untreated subjects with metastatic pancreatic...

Enrolling
Pancreatic Ductal Adenocarcinoma (PDAC)
Drug: ProAgio Dose Levels (DL) 1,2,3,4
Drug: Gemcitabine, nab paclitaxel

Phase 1

ProDa BioTech

Birmingham, Alabama, United States

A Phase I, Multicenter, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of Minnelide™Capsules given daily for 21 days...

Enrolling
Advanced Cancer
Breast Cancer
Drug: Minnelide™Capsules

Phase 1

Minneamrita Therapeutics

Birmingham, Alabama, United States and 6 other locations

of this study is to evaluate the efficacy and safety of standard chemotherapy with or without INCB161734 in participants with metastatic pancreatic...

Enrolling
Solid Tumors
Drug: Investigator's choice of chemotherapy
Drug: Placebo

Phase 3

Incyte
Incyte

Birmingham, Alabama, United States and 227 other locations

with the exception of people with advanced non-small cell lung cancer (NSCLC).Solid tumors may have specific changes or mutations to a gene ...

Enrolling
Advanced Solid Tumors
HER2 Mutation
Drug: BAY2927088

Phase 2

Bayer
Bayer

Birmingham, Alabama, United States and 55 other locations

This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with adva...

Active, not recruiting
Metastatic Cancer
Advanced Cancer
Drug: Cetuximab
Drug: Afatinib

Phase 1, Phase 2

Mirati Therapeutics
Mirati Therapeutics

Birmingham, Alabama, United States and 231 other locations

Locations recently updated

plus ponsegromab versus systemic chemotherapy plus placebo for the first-line treatment in adult participants with cachexia and metastatic pancreatic...

Enrolling
Metastatic Pancreatic Ductal Adenocarcinoma
Cachexia
Drug: placebo
Drug: ponsegromab

Phase 2, Phase 3

Pfizer
Pfizer

Birmingham, Alabama, United States and 223 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems